Veterinary Medicines

Calmasol-440, solution for infusion for cattle, sheep and pigs

Authorised
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate
  • Boric acid
Download as PDF

Product identification

Medicine name:
Calmasol-440, solution for infusion for cattle, sheep and pigs
Calmafusion, 380mg/60mg/50mg, oplossing voor infusie voor runderen, schapen en varkens
Active substance:
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate
  • Boric acid
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Calcium gluconate monohydrate
    380.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    60.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Boric acid
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Graduated polypropylene bottle, closed with a bromobutyl rubber stopper and secured with an aluminium cap. 12x500 ml.
  • Graduated polypropylene bottle, closed with a bromobutyl rubber stopper and secured with an aluminium cap. 1x500 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 125082
Date of authorisation status change:
Reference member state:
  • Estonia
Procedure number:
  • EE/V/0104/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 1/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."